X
API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
Listed Suppliers
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
0
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
61
PharmaCompass offers a list of Nitroxoline API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Nitroxoline manufacturer or Nitroxoline supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Nitroxoline manufacturer or Nitroxoline supplier.
PharmaCompass also assists you with knowing the Nitroxoline API Price utilized in the formulation of products. Nitroxoline API Price is not always fixed or binding as the Nitroxoline Price is obtained through a variety of data sources. The Nitroxoline Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Nitroxoline manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Nitroxoline, including repackagers and relabelers. The FDA regulates Nitroxoline manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Nitroxoline API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Nitroxoline supplier is an individual or a company that provides Nitroxoline active pharmaceutical ingredient (API) or Nitroxoline finished formulations upon request. The Nitroxoline suppliers may include Nitroxoline API manufacturers, exporters, distributors and traders.
click here to find a list of Nitroxoline suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Nitroxoline written confirmation (Nitroxoline WC) is an official document issued by a regulatory agency to a Nitroxoline manufacturer, verifying that the manufacturing facility of a Nitroxoline active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Nitroxoline APIs or Nitroxoline finished pharmaceutical products to another nation, regulatory agencies frequently require a Nitroxoline WC (written confirmation) as part of the regulatory process.
click here to find a list of Nitroxoline suppliers with Written Confirmation (WC) on PharmaCompass.
Nitroxoline Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Nitroxoline GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Nitroxoline GMP manufacturer or Nitroxoline GMP API supplier for your needs.
A Nitroxoline CoA (Certificate of Analysis) is a formal document that attests to Nitroxoline's compliance with Nitroxoline specifications and serves as a tool for batch-level quality control.
Nitroxoline CoA mostly includes findings from lab analyses of a specific batch. For each Nitroxoline CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Nitroxoline may be tested according to a variety of international standards, such as European Pharmacopoeia (Nitroxoline EP), Nitroxoline JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Nitroxoline USP).
Market Place
